Checkpoint Trends Stock Hits All-Time High at Rs.97.32

Strong Momentum Drives Record Price

On 27 Nov 2025, Checkpoint Trends opened and traded steadily at Rs.97.32, setting a new 52-week and all-time high price. The stock’s performance today outpaced the broader sector by 1.85%, registering a daily gain of 1.99% compared to the Sensex’s 0.34%. This price level underscores the stock’s resilience and investor confidence within the Pharmaceuticals & Biotechnology industry.

Consistent Gains Over Multiple Periods

The stock has demonstrated a remarkable run, with a consecutive gain streak spanning 21 days. Over this period, Checkpoint Trends has delivered returns of 51.33%, showcasing sustained upward movement. This trend is further supported by the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong technical foundation.

Outperformance Against Benchmarks

Checkpoint Trends’ performance over various time horizons highlights its exceptional growth relative to the Sensex benchmark. Over the past week, the stock recorded a 10.38% return, while the Sensex showed a modest 0.31%. The one-month return for Checkpoint Trends stands at 54.35%, significantly higher than the Sensex’s 1.32%.

Looking at longer durations, the stock’s three-month return is 195.81%, dwarfing the Sensex’s 6.33%. Over one year, Checkpoint Trends has delivered a remarkable 547.07% return, compared to the Sensex’s 7.06%. Year-to-date figures reveal an even more pronounced difference, with the stock at 645.75% against the Sensex’s 9.93%.

Long-Term Growth Trajectory

Checkpoint Trends’ growth over extended periods further emphasises its strong market presence. Over three years, the stock has recorded a return of 2250.72%, vastly outperforming the Sensex’s 37.90%. The five-year return stands at 4624.27%, compared to the Sensex’s 94.57%, while the ten-year return is an impressive 6611.72%, far exceeding the Sensex’s 228.77%.

Market Capitalisation and Sector Context

Operating within the Pharmaceuticals & Biotechnology sector, Checkpoint Trends holds a market capitalisation grade of 4, reflecting its standing among peers. The sector itself has seen varied performance, but Checkpoint Trends’ consistent upward trajectory and ability to maintain trading above key moving averages highlight its relative strength.

Comparative Performance Highlights

The stock’s ability to outperform the Sensex and its sector peers across short, medium, and long-term periods illustrates a sustained positive trend. The 21-day consecutive gains and the steady climb above all major moving averages provide a technical backdrop supporting the price milestone.

Summary of Checkpoint Trends’ Market Journey

Checkpoint Trends’ recent all-time high price of Rs.97.32 is the culmination of a sustained period of strong returns and steady market performance. The stock’s ability to maintain gains over 21 consecutive days and its outperformance relative to the Sensex and sector benchmarks across multiple time frames highlight a robust market position.

Trading above all key moving averages further supports the stock’s technical strength, while its market capitalisation grade reflects a solid standing within the Pharmaceuticals & Biotechnology sector. The long-term returns, spanning up to a decade, demonstrate a remarkable growth trajectory that few stocks achieve.

While the stock’s recent performance is notable, it is important to consider these figures within the broader market context. The Pharmaceuticals & Biotechnology sector continues to evolve, and Checkpoint Trends’ current valuation and price levels represent a significant milestone in its ongoing market presence.

Investors and market watchers will note the stock’s consistent upward trend and its ability to sustain gains over extended periods, marking it as a noteworthy entity within its industry.

Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →